A nasal vaccine candidate, based on S2 and N proteins from SARS-CoV-2, generates a broad antibody response systemic and at lower respiratory tract.
Yadira Lobaina, Rong Chen, Dania Vázquez‐Blomquist, Edith Suzarte, Miaohong Zhang, Zhiqiang Zhou, Yaqin Lan, Gerardo Guillén, Wen Li, Yasser Perera, Lisset Hermida
This paper evaluates a nasal SARS-CoV-2 vaccine candidate based on S2 and N proteins, showing broad antibody responses and mucosal immunity in mice.
bioRxiv · May 9, 2025 · PreprintImmunology